The healthcare conglomerate handily beat on the bottom line in its latest reported quarter, but that's not what the market ...

Cardinal's pharmaceutical and specialty solutions segment distributes branded, generic, and specialty drugs and over-the-counter healthcare and consumer products. Cardinal plays a central role in the ...

Cardinal Health reported steady fourth-quarter results and a stronger profit outlook for 2026, while expanding its specialty care platform with the acquisition of Solaris Health.

Dublin, Ohio-based Cardinal Health raised its fiscal 2026 adjusted earnings per share forecast to $9.30 to $9.50, ahead of ...

Cardinal Health's Specialty Alliance will acquire Solaris Health for $1.9 billion, enhancing its urology capabilities. The ...

The acquisition reflects Cardinal’s expanded focus on urology in pursuit of higher growth margin versus drug distribution.

Cardinal Health today reported fourth quarter fiscal year 2025 revenues of $60.2 billion, relatively flat compared to the ...

Cardinal Health, Inc. ( NYSE: CAH) Q4 2025 Earnings Conference Call August 12, 2025 8:30 AM ET Aaron E. Alt - Chief Financial Officer Jason M. Hollar - CEO & Director Matt Sims - Vice President of ...

Recent acquisitions helped to slightly lift the healthcare-products distributor’s profit and revenue, as the company faces ...

Recent acquisitions helped to slightly lift the healthcare-products distributor’s profit and revenue, as the company faces ...